Pictet North America Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-928
| Closed | -$815K | – | 148 |
|
|
2023
Q4 | $815K | Hold |
928
| – | – | 0.11% | 88 |
|
|
2023
Q3 | $764K | Hold |
928
| – | – | 0.11% | 91 |
|
|
2023
Q2 | $667K | Hold |
928
| – | – | 0.09% | 95 |
|
|
2023
Q1 | $763K | Hold |
928
| – | – | 0.12% | 86 |
|
|
2022
Q4 | $670K | Hold |
928
| – | – | 0.12% | 84 |
|
|
2022
Q3 | $639K | Hold |
928
| – | – | 0.1% | 91 |
|
|
2022
Q2 | $549K | Hold |
928
| – | – | 0.07% | 102 |
|
|
2022
Q1 | $648K | Hold |
928
| – | – | 0.08% | 93 |
|
|
2021
Q4 | $586K | Hold |
928
| – | – | 0.06% | 95 |
|
|
2021
Q3 | $562K | Hold |
928
| – | – | 0.06% | 96 |
|
|
2021
Q2 | $518K | Hold |
928
| – | – | 0.05% | 100 |
|
|
2021
Q1 | $439K | Hold |
928
| – | – | 0.05% | 100 |
|
|
2020
Q4 | $448K | Hold |
928
| – | – | 0.06% | 105 |
|
|
2020
Q3 | $519K | Hold |
928
| – | – | 0.07% | 100 |
|
|
2020
Q2 | $579K | Hold |
928
| – | – | 0.08% | 95 |
|
|
2020
Q1 | $453K | Hold |
928
| – | – | 0.08% | 108 |
|
|
2019
Q4 | $348K | Buy |
+928
| New | +$348K | 0.04% | 128 |
|